ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $256,000 | -16.9% | 7,534 | 0.0% | 0.02% | -15.8% |
Q2 2021 | $308,000 | +9.6% | 7,534 | +8.0% | 0.02% | -9.5% |
Q1 2021 | $281,000 | -48.0% | 6,978 | -23.6% | 0.02% | -43.2% |
Q4 2020 | $540,000 | +34.3% | 9,129 | +10.4% | 0.04% | +2.8% |
Q3 2020 | $402,000 | -23.4% | 8,270 | -23.8% | 0.04% | -28.0% |
Q2 2020 | $525,000 | +28.4% | 10,854 | -26.3% | 0.05% | +8.7% |
Q1 2020 | $409,000 | – | 14,731 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |